CRISPR Therapeutics AG CRSP
51.86 USD +1.87 (+3.74%)
Nov 4, 2026, 1:00 PM EST
50.19 Day range 52.45
44.12 52-week range 63.45
- YTD
- -1.11%
- 1 year
- -8.07%
Held by funds
115 US ETFs and mutual funds hold CRSP · largest positions
Ownership
Held by insiders 5.97%
Held by institutions 79.75%
Float held by institutions 84.80%
Institutions 680
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.78% | 9,460,939 | 472.95M | Jun 29, 2026 |
| Blackrock Inc. | 8.63% | 8,348,977 | 417.37M | Jun 29, 2026 |
| Orbis Allan Gray Ltd | 5.64% | 5,449,161 | 272.40M | Jun 29, 2026 |
| Capital World Investors | 4.91% | 4,749,525 | 237.43M | Jun 29, 2026 |
| State Street Corporation | 4.47% | 4,321,666 | 216.04M | Jun 29, 2026 |
| GSK plc | 3.33% | 3,220,627 | 161.00M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 6.79% | 6,568,594 | 328.36M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.81% | 2,716,415 | 135.79M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.41% | 2,325,509 | 116.25M | Sep 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.21% | 2,133,972 | 106.68M | Sep 29, 2026 |
| NEW PERSPECTIVE FUND | 2.01% | 1,944,073 | 97.18M | Sep 29, 2026 |
| SmallCap World Fund Inc | 1.75% | 1,694,327 | 84.70M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEHBAHANI ALI | Director | Sale | Sep 16, 2026 | 16,666 |
| BRUNO JULIANNE | Chief Operating Officer | Sale | Mar 20, 2025 | 17,632 |
| GEORGE SIMEON J. | Director | Purchase | Jul 15, 2025 | 0 |
| GREENE JOHN THOMAS | Director | Purchase | Feb 25, 2025 | 7,000 |
| KASINGER JAMES R. | General Counsel | Sale | Oct 5, 2026 | 94,784 |
| KULKARNI SAMARTH | Chief Executive Officer | Sale | Oct 18, 2026 | 311,899 |